Today's Medical News

Hematology & Oncology

FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma

The U.S. Food and Drug Administration on Friday expanded approval for the use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with specific types of peripheral T-cell lymphoma.


Even With Standing Orders, Naloxone Access Varies

There are great differences in access to naloxone even among states that have passed legislation to allow pharmacists to dispense the medication without a physician's prescription, according to two research letters published in the Nov. 13 issue of the Journal of the American Medical Association.

Conference Highlights

November 10 2018 - November 12 2018American Heart Association, Nov. 10-12
November 2 2018 - November 6 2018American Academy of Pediatrics, Nov. 2-6
October 27 2018 - October 30 2018American Academy of Ophthalmology, Oct. 27-30
October 23 2018 - October 28 2018American Society of Nephrology, Oct. 23-28
October 22 2018 - October 26 2018American College of Surgeons, Oct. 22-26

Monthly Briefings